chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain of skin, Paraesthesia, Skin warm, Swelling, Swelling face
Clinical narrative: I developed a headache almost immediately. Thirty minutes after receiving dose 1 of the Moderna Covid 19 vaccine my face, ears, neck, and chest turned bright red. My neck, face and ears swelled up. The skin was hot to touch and painful; it felt like pins and needles. I took one 200 mg Ibuprofen and held cool compresses to my skin. The swelling and redness subsided within 20-30 minutes. Four hours later, I was fatigued. The next day (Saturday, October 2, 2021), I was dizzy, had full body aches, joint pain, a headache, nausea, a fast heart beat (higher than normal for my resting heart rate; it was in the 120s). My arm hurt terribly at the site of injection it swelled up with a big lump, its very tender, and the skin turned red around the injection and itches. After 48 hours, the general side effects subsided. The injection site reactions have shown little to no improvement.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Menstruation delayed, Pelvic pain, Pregnancy test negative, Vaginal haemorrhage
Clinical narrative: Vaginal spotting and delayed period since the vaccine.  Constant pelvic and lower back pain since the vaccine.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatic lesion, Ultrasound liver abnormal
Clinical narrative: Liver lesions
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vitreous detachment
Clinical narrative: WENT TO OPTHALMOLOGIST I WAS DIAGNOSED WITH A POSTERIOR VITREAL DETACHMENT
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever and Chills
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, No adverse event, Syringe issue, Underdose
Clinical narrative: While administering the vaccination, the syringe separated from the needle.  It appears less than half of the dose went into the arm.  Pt reported no effects.   We will administer the second dose per CDC guidelines since it appears it was less than half the dose.
Age: 1.0
Sex: M
Vaccine: FLU4
Symptoms: Diarrhoea, Electroencephalogram, Endotracheal intubation, Intensive care, Laboratory test
Clinical narrative: ER visit 10/14/2019 via ambulance with respiratory distress, followed by diarrhea, hospitalized one day in ICU, and one day on the other floor.  Discharged on 10/16/19 around 4:00 P.M.  Returned to the  ER  via ambulance on 10/16/19 around 8:00 P.M. with  seizures, was later  intubated for three weeks, remained in the hospital for five weeks,  followed by a week and 1/2 of rehabilitation in a different hospital.  Has required PT, OT, Speech, Special Education, seizure meds, MRI and numerous of other medical issues.
Age: 1.0
Sex: M
Vaccine: FLU4
Symptoms: Magnetic resonance imaging, Respiratory distress, Seizure
Clinical narrative: ER visit 10/14/2019 via ambulance with respiratory distress, followed by diarrhea, hospitalized one day in ICU, and one day on the other floor.  Discharged on 10/16/19 around 4:00 P.M.  Returned to the  ER  via ambulance on 10/16/19 around 8:00 P.M. with  seizures, was later  intubated for three weeks, remained in the hospital for five weeks,  followed by a week and 1/2 of rehabilitation in a different hospital.  Has required PT, OT, Speech, Special Education, seizure meds, MRI and numerous of other medical issues.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alanine aminotransferase increased, Anion gap, Antibody test negative, Aspartate aminotransferase increased
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Basophil percentage decreased, Bilirubin conjugated increased, Blood albumin decreased, Blood alkaline phosphatase normal, Blood bilirubin increased
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Blood chloride decreased, Blood creatine phosphokinase increased, Blood creatinine normal, Blood culture, Blood fibrinogen increased
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood group A, Blood lactate dehydrogenase increased, Blood lactic acid, Blood potassium normal
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, Blood urea normal, Brain natriuretic peptide decreased, C-reactive protein increased, COVID-19
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Carbon dioxide normal, Chest X-ray abnormal, Cough, Eosinophil percentage
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Glomerular filtration rate, HIV test negative, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatitis B core antibody negative, Hepatitis C antibody negative, Hypoxia, Immature granulocyte count, International normalised ratio increased
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Lipase normal, Liver function test increased, Lung opacity, Lymphocyte percentage decreased, Mean cell volume normal
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Monocyte percentage increased, Neutrophil percentage increased, Oxygen saturation decreased, Pain, Platelet count normal
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Protein total decreased, Pyrexia, Red blood cell count decreased, Red cell distribution width normal, SARS-CoV-2 test positive
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Serum ferritin increased, Transaminases, Troponin I normal, Ultrasound abdomen normal, White blood cell count normal
Clinical narrative: 78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14.  COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED   COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home.   Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Age: 13.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Chest X-ray normal, Dyspnoea, Electrocardiogram, Heart rate increased
Clinical narrative: Had shortness of breath and accelerated heart 60 minutes after vaccine.  The about two hrs later numbness on left side of face, neck shoulder, arm, hand, hip, leg and foot, which got worse as the day wore on.  Excruciating pain in left leg and arm  for two days, and numbness in left side for two day but numbness in left side of face is still present.  Numbness around the left eye is also present and my eye is cloudy and have trouble focusing on reading material and I've not had this problem before the vaccine.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia, Visual impairment
Clinical narrative: Had shortness of breath and accelerated heart 60 minutes after vaccine.  The about two hrs later numbness on left side of face, neck shoulder, arm, hand, hip, leg and foot, which got worse as the day wore on.  Excruciating pain in left leg and arm  for two days, and numbness in left side for two day but numbness in left side of face is still present.  Numbness around the left eye is also present and my eye is cloudy and have trouble focusing on reading material and I've not had this problem before the vaccine.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hyperpyrexia, Impaired work ability
Clinical narrative: The next day on Thursday at about 4 or 5 in the evening I had started to have headaches, a high fever, and dizziness. I still had a fever on Friday morning so I didn't go into work.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Anticoagulant therapy, COVID-19, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Patient described shortness of breath and stomach pains. Sent to Emergency room via EMS and tested positive for COVID-19 Delta variant 12 days after vaccine. Upon X-ray of chest, small blood clot located into right lower lobe. Admitted into hospital for observation and released 2 days later with blood thinner and antibiotics. No other symptoms reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary thrombosis, SARS-CoV-2 test positive
Clinical narrative: Patient described shortness of breath and stomach pains. Sent to Emergency room via EMS and tested positive for COVID-19 Delta variant 12 days after vaccine. Upon X-ray of chest, small blood clot located into right lower lobe. Admitted into hospital for observation and released 2 days later with blood thinner and antibiotics. No other symptoms reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Myalgia
Clinical narrative: Muscle aches, headaches, soreness at injection site, fatigue, slight fever all lasting about 24 hours
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Blindness, Blood test, Fatigue, Muscle spasms, Muscular weakness
Clinical narrative: Pt. states that after receiving the 1st dose of J&J 03/11/2021, started experiencing symptoms 03/18/2021 of night sweats, leg weakness and shaking, vision loss, leg cramping, fatigue, and muscle aches. Emergency Room visit 10/04/2021, Blood Work and Observation. Pt. continues to experience symptoms.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Night sweats, Tremor
Clinical narrative: Pt. states that after receiving the 1st dose of J&J 03/11/2021, started experiencing symptoms 03/18/2021 of night sweats, leg weakness and shaking, vision loss, leg cramping, fatigue, and muscle aches. Emergency Room visit 10/04/2021, Blood Work and Observation. Pt. continues to experience symptoms.
Age: 22.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dyspnoea, Headache, Heart rate increased
Clinical narrative: Evening of April 30 after second vaccination, had a rapid continual heart beat along with shortness of breath and an excruciating headache.  The headache continued through 2 o'clock on May 1.  It resolved finally with some Tylenol. The rapid heart rate and shortness of breath continued with exertion along with some mild chest pain. This all continued for a couple of months until I began acupuncture treatments. I did not seek medical treatment.  I had a physical a few months ago and let my doctor know, Dr. He ran a cardiac enzyme blood test on me that came back within normal limits.  I am doing better now, but I occasionally do have a strange sensation in my chest after exertion at times since then.  Not sure if that could be the mitral valve regurgitation getting worse, but I had not had that sensation ever before my second vaccination.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin I normal
Clinical narrative: Evening of April 30 after second vaccination, had a rapid continual heart beat along with shortness of breath and an excruciating headache.  The headache continued through 2 o'clock on May 1.  It resolved finally with some Tylenol. The rapid heart rate and shortness of breath continued with exertion along with some mild chest pain. This all continued for a couple of months until I began acupuncture treatments. I did not seek medical treatment.  I had a physical a few months ago and let my doctor know, Dr. He ran a cardiac enzyme blood test on me that came back within normal limits.  I am doing better now, but I occasionally do have a strange sensation in my chest after exertion at times since then.  Not sure if that could be the mitral valve regurgitation getting worse, but I had not had that sensation ever before my second vaccination.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Headache, Pain, Pain in extremity
Clinical narrative: fever, chills, body aches and headache for 24 hours.  Sore arm and underarm
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever, chills, body aches and headache for 24 hours.  Sore arm and underarm
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 14.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Blood pressure increased, Chest X-ray, Disorientation, Dyspnoea
Clinical narrative: Pt had a syncopal episode that evening of vaccination, the following morning he had 2 episodes of syncope. The last one that happened on Friday morning at 7am  the patient was reportedly convulsing, diaphoretic and disoriented- blood pressure was 220/100. Son also reported he was not responsive to sound or voice and his breathing became labored for a short time after the convulsing stopped.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Electrocardiogram, Hyperhidrosis, Metabolic function test, Seizure
Clinical narrative: Pt had a syncopal episode that evening of vaccination, the following morning he had 2 episodes of syncope. The last one that happened on Friday morning at 7am  the patient was reportedly convulsing, diaphoretic and disoriented- blood pressure was 220/100. Son also reported he was not responsive to sound or voice and his breathing became labored for a short time after the convulsing stopped.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope, Troponin, Unresponsive to stimuli, Urine analysis
Clinical narrative: Pt had a syncopal episode that evening of vaccination, the following morning he had 2 episodes of syncope. The last one that happened on Friday morning at 7am  the patient was reportedly convulsing, diaphoretic and disoriented- blood pressure was 220/100. Son also reported he was not responsive to sound or voice and his breathing became labored for a short time after the convulsing stopped.
Age: 67.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Chest discomfort, Hypoaesthesia
Clinical narrative: Patient stated chest tightness and her arm felt numb. started about 10 minutes after patient had vaccine.
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure increased, Chest discomfort, Feeling abnormal, Palpitations
Clinical narrative: Pt states, received the vaccine 10/1/2021, about 9 am, waited 15 minutes following vaccine, felt okay.  Awoke the next morning  10/2/2021.about 430 am from symptoms tachycardia, bounding pulse, chest tightness/discomfort. Pt states she doesn't describe as chest pain. No Shortness of breath. Went back to sleep.    At about 11am, symptoms felt: no energy, not feeling right. Decided to check blood pressure 238/152. Took PRN medication Clonidine, in addition to relaxed, non-pharmacy interventions to bring blood pressure down.   Clonidine and Baby ASA (81 mg).  Denies symptoms of chest pain, jaw pain, shortness of breath.   Pt reported the hypertension symptoms improved. Did not report actual numbers.    Does not believe symptoms were related to anxiety of getting the vaccination.    10/4/2021: symptoms: energy is not back. checked blood pressure today, still slightly elevated but much improved.  "doing what I need to do to keep it down. Denies chest pain, shortness of breath. "I manage my blood pressure without medications, my doctor works with me to manage without medication,. I made some lifestyle changes".  Pt "does not feel at risk" to go to the ED or be seen at this time, wanted information documented. Taking action at home to bring blood pressure down.    Clinic provider notified for review.  Recommend office visit for blood pressure check. Per patient, sounds like symptoms are under control.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Pt states, received the vaccine 10/1/2021, about 9 am, waited 15 minutes following vaccine, felt okay.  Awoke the next morning  10/2/2021.about 430 am from symptoms tachycardia, bounding pulse, chest tightness/discomfort. Pt states she doesn't describe as chest pain. No Shortness of breath. Went back to sleep.    At about 11am, symptoms felt: no energy, not feeling right. Decided to check blood pressure 238/152. Took PRN medication Clonidine, in addition to relaxed, non-pharmacy interventions to bring blood pressure down.   Clonidine and Baby ASA (81 mg).  Denies symptoms of chest pain, jaw pain, shortness of breath.   Pt reported the hypertension symptoms improved. Did not report actual numbers.    Does not believe symptoms were related to anxiety of getting the vaccination.    10/4/2021: symptoms: energy is not back. checked blood pressure today, still slightly elevated but much improved.  "doing what I need to do to keep it down. Denies chest pain, shortness of breath. "I manage my blood pressure without medications, my doctor works with me to manage without medication,. I made some lifestyle changes".  Pt "does not feel at risk" to go to the ED or be seen at this time, wanted information documented. Taking action at home to bring blood pressure down.    Clinic provider notified for review.  Recommend office visit for blood pressure check. Per patient, sounds like symptoms are under control.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: The night after receiving my COVID booster my left axillary lymph node began to swell and become sore to the touch. % days later the swelling and soreness is still present.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Dizziness, Ear swelling, Headache
Clinical narrative: Dizziness, headaches, diarreah, fever, ER on 02/08/2021 was given 2 bags of fluid. Ear began swelling, loss of apetite, neck and scalp itchy.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: Dizziness, headaches, diarreah, fever, ER on 02/08/2021 was given 2 bags of fluid. Ear began swelling, loss of apetite, neck and scalp itchy.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Acute respiratory failure, Angiogram pulmonary abnormal, COVID-19, Computerised tomogram abdomen abnormal
Clinical narrative: Hospitalized 09/23/2021; COVID-19 positive 09/17/2021; fully vaccinated  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure (HCC) [J96.01] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: 73-year-old female with history of chronic respiratory failure on 3-4 L of oxygen at baseline, chronic obstructive pulmonary disease, previous colorectal cancer, OSA, and aortic stenosis who presented with worsening dyspnea, hypoxia, hemoptysis, abdominal pain, and diarrhea after being diagnosed with COVID-19 9-17.  She had symptoms for 2 weeks prior to admission.  The patient required non-rebreather while in the emergency department.  CTA was negative for PE, but showed diffuse bilateral peripheral airspace disease.  CT of the abdomen and pelvis showed an atrophic pancreas, but no acute process.  Steroids were started in the emergency department and the patient was admitted to the hospitalist service for further continuation of care.  The patient's oxygen requirement worsened to the point where she was on 100% via high-flow nasal cannula.  Her diarrhea and abdominal pain improved without intervention.  IV vancomycin was started as her sputum culture grew Staph aureus.  IV Lasix was administered.  The patient was discussed with pulmonology who reported that prognosis was poor in the setting of her pre-existing lung disease.  Goals of care were discussed with the patient by this provider.  The patient was clear that she would not want intubation and mechanical ventilation in the case of worsening respiratory failure.  The patient desaturated overnight 9-25 the and was hypoxic despite high-flow nasal cannula and non-rebreather.  Comfort measures were initiated after discussion with the patient and her son.  The patient passed away 09/26/2021 at 11:40 with family at bedside.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Death, Diarrhoea, Dyspnoea, Haemoptysis
Clinical narrative: Hospitalized 09/23/2021; COVID-19 positive 09/17/2021; fully vaccinated  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure (HCC) [J96.01] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: 73-year-old female with history of chronic respiratory failure on 3-4 L of oxygen at baseline, chronic obstructive pulmonary disease, previous colorectal cancer, OSA, and aortic stenosis who presented with worsening dyspnea, hypoxia, hemoptysis, abdominal pain, and diarrhea after being diagnosed with COVID-19 9-17.  She had symptoms for 2 weeks prior to admission.  The patient required non-rebreather while in the emergency department.  CTA was negative for PE, but showed diffuse bilateral peripheral airspace disease.  CT of the abdomen and pelvis showed an atrophic pancreas, but no acute process.  Steroids were started in the emergency department and the patient was admitted to the hospitalist service for further continuation of care.  The patient's oxygen requirement worsened to the point where she was on 100% via high-flow nasal cannula.  Her diarrhea and abdominal pain improved without intervention.  IV vancomycin was started as her sputum culture grew Staph aureus.  IV Lasix was administered.  The patient was discussed with pulmonology who reported that prognosis was poor in the setting of her pre-existing lung disease.  Goals of care were discussed with the patient by this provider.  The patient was clear that she would not want intubation and mechanical ventilation in the case of worsening respiratory failure.  The patient desaturated overnight 9-25 the and was hypoxic despite high-flow nasal cannula and non-rebreather.  Comfort measures were initiated after discussion with the patient and her son.  The patient passed away 09/26/2021 at 11:40 with family at bedside.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Lung disorder, Pancreatic atrophy, SARS-CoV-2 test positive, Sputum culture positive
Clinical narrative: Hospitalized 09/23/2021; COVID-19 positive 09/17/2021; fully vaccinated  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure (HCC) [J96.01] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: 73-year-old female with history of chronic respiratory failure on 3-4 L of oxygen at baseline, chronic obstructive pulmonary disease, previous colorectal cancer, OSA, and aortic stenosis who presented with worsening dyspnea, hypoxia, hemoptysis, abdominal pain, and diarrhea after being diagnosed with COVID-19 9-17.  She had symptoms for 2 weeks prior to admission.  The patient required non-rebreather while in the emergency department.  CTA was negative for PE, but showed diffuse bilateral peripheral airspace disease.  CT of the abdomen and pelvis showed an atrophic pancreas, but no acute process.  Steroids were started in the emergency department and the patient was admitted to the hospitalist service for further continuation of care.  The patient's oxygen requirement worsened to the point where she was on 100% via high-flow nasal cannula.  Her diarrhea and abdominal pain improved without intervention.  IV vancomycin was started as her sputum culture grew Staph aureus.  IV Lasix was administered.  The patient was discussed with pulmonology who reported that prognosis was poor in the setting of her pre-existing lung disease.  Goals of care were discussed with the patient by this provider.  The patient was clear that she would not want intubation and mechanical ventilation in the case of worsening respiratory failure.  The patient desaturated overnight 9-25 the and was hypoxic despite high-flow nasal cannula and non-rebreather.  Comfort measures were initiated after discussion with the patient and her son.  The patient passed away 09/26/2021 at 11:40 with family at bedside.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Staphylococcal infection
Clinical narrative: Hospitalized 09/23/2021; COVID-19 positive 09/17/2021; fully vaccinated  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure (HCC) [J96.01] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: 73-year-old female with history of chronic respiratory failure on 3-4 L of oxygen at baseline, chronic obstructive pulmonary disease, previous colorectal cancer, OSA, and aortic stenosis who presented with worsening dyspnea, hypoxia, hemoptysis, abdominal pain, and diarrhea after being diagnosed with COVID-19 9-17.  She had symptoms for 2 weeks prior to admission.  The patient required non-rebreather while in the emergency department.  CTA was negative for PE, but showed diffuse bilateral peripheral airspace disease.  CT of the abdomen and pelvis showed an atrophic pancreas, but no acute process.  Steroids were started in the emergency department and the patient was admitted to the hospitalist service for further continuation of care.  The patient's oxygen requirement worsened to the point where she was on 100% via high-flow nasal cannula.  Her diarrhea and abdominal pain improved without intervention.  IV vancomycin was started as her sputum culture grew Staph aureus.  IV Lasix was administered.  The patient was discussed with pulmonology who reported that prognosis was poor in the setting of her pre-existing lung disease.  Goals of care were discussed with the patient by this provider.  The patient was clear that she would not want intubation and mechanical ventilation in the case of worsening respiratory failure.  The patient desaturated overnight 9-25 the and was hypoxic despite high-flow nasal cannula and non-rebreather.  Comfort measures were initiated after discussion with the patient and her son.  The patient passed away 09/26/2021 at 11:40 with family at bedside.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Computerised tomogram abdomen normal, Diarrhoea, Full blood count normal, Metabolic function test normal
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: Hospitalization Patient received Pfizer Vaccines on 9/8/2021 and 9/30/2021. Presented to ED on 9/30/2021 with severe crampy abdominal pain, diarrhea, nausea after receiving her second COVID-19 vaccine earlier in the day. On arrival the patient was tachycardic up to 120s (states tachycardic at baseline). Covid test was negative. UA negative. CMP and CBC WNL. US of pelvis and CT A/P were negative. Patient was treated with zofran, morphine x1, LR and atarax. Abdominal pain resolved by the morning of 10/1/2021 and patient was discharged.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, SARS-CoV-2 test negative, Tachycardia, Ultrasound pelvis normal, Urine analysis normal
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: Hospitalization Patient received Pfizer Vaccines on 9/8/2021 and 9/30/2021. Presented to ED on 9/30/2021 with severe crampy abdominal pain, diarrhea, nausea after receiving her second COVID-19 vaccine earlier in the day. On arrival the patient was tachycardic up to 120s (states tachycardic at baseline). Covid test was negative. UA negative. CMP and CBC WNL. US of pelvis and CT A/P were negative. Patient was treated with zofran, morphine x1, LR and atarax. Abdominal pain resolved by the morning of 10/1/2021 and patient was discharged.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site erythema, Injection site swelling, Injection site vesicles
Clinical narrative: Blistering lesions at injection site and subsequent redness and swelling spreading from this site and development of pain in shoulder joint adjacent to injection site.  Treatment is involving methylprednisolone oral taper and valacyclovir for 7 days.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Angioedema, Migraine, Swelling
Clinical narrative: Approximately 1hr after first dose symptoms began with the onset of a migraine center at the back of head. neck swelling and  angioedema diffused. Individual use Benadryl to manage symptoms. How ever swelling remained to the next day.
Age: 80.0
Sex: F
Vaccine: FLUA4
Symptoms: Extra dose administered
Clinical narrative: Patient came to a flu shot clinic today expecting a Moderna booster shot. After receiving the shot, she stated she already received the yearly flu shot at her PCP office. At the office she received the Fluzone HD. No issues were reported today after getting a second flu shot.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchial hyperreactivity, COVID-19, Condition aggravated, Cough, Dyspnoea
Clinical narrative: Breakthrough COVID-19 case with symptom onset 5/20/2021: Runny Nose/Congestion, Shortness of breath/difficulty breathing, Fatigue or tiredness, Cough. Hospitalized 5/24/2021-5/26/2021: presented to the ED with S0B and productive cough, found to have diffuse expiratory wheezing, admitted for exacerbation of unspecified reactive airway disease. Positive COVID-19 TEST. She was discharged home in good condition.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasal congestion, Productive cough, Rhinorrhoea, SARS-CoV-2 antibody test positive
Clinical narrative: Breakthrough COVID-19 case with symptom onset 5/20/2021: Runny Nose/Congestion, Shortness of breath/difficulty breathing, Fatigue or tiredness, Cough. Hospitalized 5/24/2021-5/26/2021: presented to the ED with S0B and productive cough, found to have diffuse expiratory wheezing, admitted for exacerbation of unspecified reactive airway disease. Positive COVID-19 TEST. She was discharged home in good condition.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection, Wheezing
Clinical narrative: Breakthrough COVID-19 case with symptom onset 5/20/2021: Runny Nose/Congestion, Shortness of breath/difficulty breathing, Fatigue or tiredness, Cough. Hospitalized 5/24/2021-5/26/2021: presented to the ED with S0B and productive cough, found to have diffuse expiratory wheezing, admitted for exacerbation of unspecified reactive airway disease. Positive COVID-19 TEST. She was discharged home in good condition.
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: No adverse event, Underdose
Clinical narrative: PATIENT RECEIVED THE PEDIATRIC DOSE OF ENERGIX-B RATHER THAN THE ADULT DOSE. NO ADVERSE EFFECTS WERE NOTED.
Age: 99.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash papular, Treponema test negative
Clinical narrative: patient had pinpoint palpable rash on hands and feet - intially painful.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Hypoaesthesia, Loss of personal independence in daily activities, Muscle spasms
Clinical narrative: Fatigue started at 8pm and was sudden onset, but felt like I couldn't move. Extreme exhaustion remained through the night and an additional 2 days. Activities of daily living were very difficult. I developed numbness in my arms(from elbows to hands) that still persists today. I also suffered from cramping in my lower legs, preventing me from sleeping or getting comfortable. The cramping turned to muscle spasms
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Fatigue started at 8pm and was sudden onset, but felt like I couldn't move. Extreme exhaustion remained through the night and an additional 2 days. Activities of daily living were very difficult. I developed numbness in my arms(from elbows to hands) that still persists today. I also suffered from cramping in my lower legs, preventing me from sleeping or getting comfortable. The cramping turned to muscle spasms
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID on 9/30/21 after being fully vaccinated.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Chills, Fatigue, Headache
Clinical narrative: Fever, chills, myalgia, arthralgia, "bone pain," fatigue, nausea, vomiting, headache
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Fever, chills, myalgia, arthralgia, "bone pain," fatigue, nausea, vomiting, headache
Age: 60.0
Sex: F
Vaccine: FLUC4
Symptoms: Rash
Clinical narrative: patient developed a rash under her armpit the day after receiving injection on the same side as injection
Age: 52.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Product preparation issue
Clinical narrative: Patient was inadvertently given dose of Pfizer that  did not have diluent added, she received 0.3 ml full dose of vaccine
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pt tested positive for COVID on 9/24/21 s/p 2 doses of Pfizer (last dose 5/10/21); was admitted to hospital on 10/4/21. Of note, pt is immunocompromised w/ Lupus receiving tx w/ Rituxan
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chest pain, Condition aggravated, Cough, Headache
Clinical narrative: When I got the vaccine, I had no real adverse symptoms - just a little pain in my arm (at (left arm).  Got sick in September starting on the 14th - on the first day, I thought I was getting a cold, went to work the next day; Thursday, the 16th, I called in - got a pretty severe sore throat during the night. I didn't know if I had the variant or not. Thursday, Friday I stayed home from work. I had various sort of not feeling well symptoms. Friday night, I threw up and had  really bad headache. I went to Urgent Care. They gave me shots of medicine - for nausea and for headache. Felt better the next day, headache did come back though. I developed a cough. The work place said to stay home on Monday. After Monday, I went back to work. I didn't have trouble breathing or chest pains at that point and so it felt more like a flu or cold. Just took at-home remedies - cough drops and Acetaminophen. I didn't have chest pain increases during this time. At Urgent Care, the doctor also prescribed me a new kind of medicine for my headaches - very similar to Excedrin - caffeine, Tylenol and a different type of medicine to help with headaches - preventative measure.   Note: Chest pain - I had been experiencing that off and on since before I had COVID and the COVID vaccines - had xrays done. It hasn't been too bad - it hasn't been real severe. I would say it a little bit continuing after the x-rays were done in June.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Impaired work ability, Influenza like illness, Malaise, Nasopharyngitis
Clinical narrative: When I got the vaccine, I had no real adverse symptoms - just a little pain in my arm (at (left arm).  Got sick in September starting on the 14th - on the first day, I thought I was getting a cold, went to work the next day; Thursday, the 16th, I called in - got a pretty severe sore throat during the night. I didn't know if I had the variant or not. Thursday, Friday I stayed home from work. I had various sort of not feeling well symptoms. Friday night, I threw up and had  really bad headache. I went to Urgent Care. They gave me shots of medicine - for nausea and for headache. Felt better the next day, headache did come back though. I developed a cough. The work place said to stay home on Monday. After Monday, I went back to work. I didn't have trouble breathing or chest pains at that point and so it felt more like a flu or cold. Just took at-home remedies - cough drops and Acetaminophen. I didn't have chest pain increases during this time. At Urgent Care, the doctor also prescribed me a new kind of medicine for my headaches - very similar to Excedrin - caffeine, Tylenol and a different type of medicine to help with headaches - preventative measure.   Note: Chest pain - I had been experiencing that off and on since before I had COVID and the COVID vaccines - had xrays done. It hasn't been too bad - it hasn't been real severe. I would say it a little bit continuing after the x-rays were done in June.